A Four Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2A Study Of PH-797804 In The Treatment Of Post-Herpetic Neuralgia.
Phase of Trial: Phase II
Latest Information Update: 13 May 2011
At a glance
- Drugs PH 797804 (Primary)
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Therapeutic Use
- 28 Apr 2011 Actual initiation date changed from 1 Mar 2008 to 1 Apr 2008 as reported by ClinicalTrials.gov.
- 10 Feb 2009 Actual patient numbers (72) added as reported by ClinicalTrials.gov.
- 18 Dec 2008 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.